TNBC
Clinical trials for TNBC explained in plain language.
Never miss a new study
Get alerted when new TNBC trials appear
Sign up with your email to follow new studies for TNBC, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a probiotic boost breast cancer treatment? new trial aims to find out
Disease control Not yet recruitingThis Phase II trial will test whether adding a live biotherapeutic product called MO-03 (a type of probiotic) to standard chemotherapy and the immunotherapy drug pembrolizumab can improve outcomes for 50 people with early-stage triple-negative breast cancer. Participants will tak…
Matched conditions: TNBC
Phase: PHASE2 • Sponsor: Yuan Yuan • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New combo therapy aims to wipe out early triple-negative breast cancer before surgery
Disease control Not yet recruitingThis study tests whether adding the immunotherapy drug camrelizumab to chemotherapy and radiation before surgery can eliminate all signs of early-stage triple-negative breast cancer. About 43 women with newly diagnosed, untreated disease will receive the combination for 12 weeks,…
Matched conditions: TNBC
Phase: NA • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
New drug duo targets hard-to-treat breast cancer in early trial
Disease control Not yet recruitingThis study tests a combination of two drugs, inavolisib and eribulin, in people with advanced triple-negative breast cancer that has a PIK3CA mutation and has not responded to at least one prior treatment. The goal is to see if the combination shrinks tumors and is safe. About 26…
Matched conditions: TNBC
Phase: PHASE2 • Sponsor: Hu Hai • Aim: Disease control
Last updated Jun 27, 2026 09:09 UTC